Profile
AKU DHR-PB TMO DHR IDXX A
Company Name Akumin Inc. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $26.27M $916.76B $160.15B $141.09B $35.45B $30.30B
Employees 1.74K 79.00K 125.00K 61.00K 11.00K 17.90K
CEO Mr. Riadh Zine-El-Abidine Mr. Rainer M. Blair Mr. Marc N. Casper Mr. Rainer M. Blair Mr. Jonathan J. Mazelsky Mr. Padraig McDonnell
Ratings
AKU DHR-PB TMO DHR IDXX A
Quant Rating Score 3 5 3 3 3 3
Quant Rating Neutral Strong Buy Neutral Neutral Neutral Neutral
Trading
AKU DHR-PB TMO DHR IDXX A
Last Close $0.2887 $1261.26 $424.24 $197.14 $437.44 $106.28
High 52 $0.29 $1261.26 $624.21 $280.76 $548.53 $154.64
Low 52 $0.29 $1261.26 $419.59 $174.64 $361.04 $99.29
Price vs. 52 Week High -0.45 % 0 % -32.04 % -29.78 % -20.25 % -31.27 %
Price vs. 52 Week Low -0.45 % 0 % 1.11 % 12.88 % 21.16 % 7.04 %
Total Return
AKU DHR-PB TMO DHR IDXX A
1 Month Return 0 % 0 % -17.41 % -6.31 % 4.72 % -11.36 %
3 Month Return 0 % 0 % -26.2 % -19.8 % 0.48 % -29.82 %
6 Month Return 0 % 0 % -23.47 % -19.66 % -3.09 % -18.37 %
9 Month Return 0 % 0 % -30.12 % -28.03 % -6.87 % -22.6 %
YTD Return 0 % 0 % -18.45 % -14.12 % 5.8 % -20.89 %
1 Year Return 0 % 0 % -26.04 % -20.05 % -12.39 % -22.84 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AKU DHR-PB TMO DHR IDXX A
Dividend Yield Percentage (TTM) - 0.58 % 0.38 % 0.57 % - 0.91 %
Dividend Paid and Capex Coverage Ration (TTM) 1.46 % 2.93 % 4.05 % 2.93 % 7.1 % 3.01 %
Dividend Per Share (TTM) - 1.13 % 1.6 % 1.13 % - 0.97 %
Payout Ratio (TTM) - 20.85 % 9.16 % 20.85 % - 21.92 %
Growth
AKU DHR-PB TMO DHR IDXX A
Asset Growth -8.01 % -8.22 % -1.42 % -8.22 % 1.03 % 10.06 %
Gross Profit Growth 130.27 % 1.23 % 5.81 % 1.23 % 8.63 % 2.02 %
Revenue Growth 78.03 % -0.06 % 0.05 % -0.06 % 6.46 % -4.73 %
Revenue 3 Year 125.3 % -21.41 % 12.79 % -21.41 % 25.48 % 8 %
Revenue 5 Year 145.38 % 29.31 % 75.79 % 29.31 % 69.43 % 36.52 %
Revenue 10 Year 1130.97 % 14.22 % 164.64 % 14.22 % 219.02 % 7.08 %
EBIT Growth 218.64 % -6.52 % 6.97 % -6.52 % 2.84 % 10.22 %
Net Income Growth -335.42 % -18.16 % 5.67 % -18.16 % 5.07 % 3.95 %
Net Income 3 Yeari Growth Per Share -1403.08 % -41.24 % -15.42 % -41.24 % 23.4 % 11.67 %
Net Income 5 Yeari Growth Per Share -515.43 % 25.73 % 79.48 % 25.73 % 117.19 % 30.32 %
Net Income 10 Yeari Growth Per Share -3090.62 % 42.96 % 248.59 % 42.96 % 493.59 % 197.81 %
Operating Income Growth 218.64 % -6.52 % 6.97 % -6.52 % 2.84 % 10.22 %
Operating Cash Flow Growth (CFG) 283.38 % -6.64 % 3.1 % -6.64 % 2.48 % -1.19 %
Operating 3 Year CFG 144.78 % -22.42 % -6.33 % -22.42 % 27.28 % 23.6 %
Operating 5 Year CFG 290.94 % 64.18 % 82.49 % 64.18 % 111.7 % 85.69 %
Operating 10 Year CFG 3845.62 % 69.53 % 244.88 % 69.53 % 379.04 % 182 %
EPS Growth -275.56 % -17.86 % 6.76 % -17.86 % 6.1 % 5.21 %
EPS Diluted Growth -275.56 % -17.08 % 7.06 % -17.08 % 6.26 % 5.73 %
Book Value Per Share -62.21 % -7.44 % 7.15 % -7.44 % 8.46 % 2.3 %
Share Holder 3 Year Equity Growth Per Share -125.84 % 6.35 % 25.29 % 6.35 % 139.34 % 14.73 %
Share Holder 5 Year Equity Growth Per Share -122.47 % 58.77 % 74.85 % 58.77 % 840.53 % 34.5 %
Share Holder 10 Year Equity Growth Per Share -771.43 % 101.9 % 151.37 % 101.9 % 1550.96 % 27.76 %
Dividend Per Share Growth - -6.53 % 12.64 % -6.53 % - 4.82 %
Dividend 3 Year Growth Per Share - 0.35 % 52.23 % 0.35 % - 21.71 %
Dividend 5 Year Growth Per Share - 41.45 % 105.55 % 41.45 % - 44.02 %
Dividend 10 Year Growth Per Share - 221.34 % 158.83 % 221.34 % - 78.77 %
Debt Growth 2.75 % -18.07 % -10.43 % -18.07 % -7.53 % 23.95 %
Free Cash Flow Growth 2622.03 % -8.39 % 4.91 % -8.39 % 3.26 % -6.85 %
Updated On 31 Dec 2022 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Oct 2024
Profitability
AKU DHR-PB TMO DHR IDXX A
Gross Profit Margin TTM 18.84 % 59.74 % 41.74 % 59.74 % 61.08 % 53.97 %
Return on Assets TTM -8.59 % 4.76 % 6.58 % 4.76 % 26.96 % 10.57 %
Return on Equity TTM -531.99 % 7.47 % 13.34 % 7.47 % 55.82 % 20.95 %
Return on Capital Employed TTM 2.61 % 6.66 % 8.53 % 6.66 % 50.78 % 14.73 %
Net Income Per EBT TTM 105.87 % 83.59 % 92.18 % 83.59 % 80 % 84.78 %
EBT Per Ebit TTM -343.69 % 93.35 % 96.45 % 93.35 % 98.21 % 100.34 %
EBIT Per Revenue TTM 5.56 % 20.26 % 17.08 % 20.26 % 28.99 % 22.65 %
Cash Flow To Debt Ratio TTM 4.42 % 37.92 % 23.81 % 37.92 % 94.13 % 50.46 %
Receivables Turnover TTM 6.57 6.79 5.07 6.79 6.94 4.92
Payables Turnover TTM 16.61 5.57 - 5.57 13.28 5.5
Inventory Turnover TTM 76.02 3.79 4.78 3.79 3.97 3.02
Fixed Asset Turnover TTM 193.19 % 466.14 % 459.74 % 466.14 % 470 % 359.75 %
Asset Turnover TTM 42.47 % 30.11 % 43.31 % 30.11 % 118.34 % 54.83 %
Operating Cash Flow Per Share TTM 0.73 8.72 21.53 8.72 11.29 5.95
Free Cash Flow Per Share TTM 0.23 6.84 17.79 6.84 9.7 4.94
Cash Per Share TTM 66.43 % 278.24 % 1573.28 % 278.24 % 350.25 % 514.74 %
Operating Cash Flow Sales Ratio TTM 8.72 % 26.23 % 18.97 % 26.23 % 23.84 % 25.98 %
Free Cash Flow Operating Cash Flow Ratio TTM 31.52 % 78.46 % 82.61 % 78.46 % 85.91 % 83.03 %
Cash Flow Coverage Ratios TTM 4.42 % 37.92 % 23.81 % 37.92 % 94.13 % 50.46 %
Price To Free Cash Flows Ratio TTM 1.27 28.68 23.82 28.78 44.42 21.51
Price To Operating Cash Flows Ratio TTM 0.4 22.53 19.7 22.6 38.75 17.85
Price Cash Flow Ratio TTM 0.4 22.53 19.7 22.6 38.75 17.85
Income Statement (TTM)
AKU DHR-PB TMO DHR IDXX A
Revenue $0.75B $23.88B $42.88B $23.88B $3.9B $6.51B
Gross Profit $0.14B $14.21B $18.11B $14.21B $2.38B $3.54B
Gross Profit Ratio 18.84% 59.5% 42.23% 59.5% 61.04% 54.3%
EBITDA $0.14B $4.86B $11.54B $4.86B $1.27B $1.49B
Net Income $-0.15B $3.9B $6.34B $3.9B $0.89B $1.29B
EPS Diluted -1.69 5.29 16.53 5.29 10.67 4.43
Balance Sheet (MRQ)
AKU DHR-PB TMO DHR IDXX A
Long Term Debt $1.43B $15.5B $29.06B $15.5B $0.55B $3.35B
Total Liabilities $1.62B $27.99B $47.65B $27.99B $1.7B $5.95B
Total Equity $0B $49.55B $49.67B $49.55B $1.6B $5.9B
Total Investments $0B $0B $1.56B $0B $0.06B $0.18B
Total Debt $1.48B $16.01B $31.28B $16.01B $0.99B $3.39B
Total Assets $1.77B $77.54B $97.32B $77.54B $3.29B $11.85B
Cash Flow Statement (TTM)
AKU DHR-PB TMO DHR IDXX A
Net Income $-0.15B $3.9B $6.34B $3.9B $0.89B $1.29B
Inventory $0B $0.15B $0B $0.15B $-0.03B $0.03B
Dividends Paid $0B $-0.77B $-0.58B $-0.77B $0B $-0.27B
Operating Cash Flow $0.07B $6.69B $8.67B $6.69B $0.93B $1.75B
Capital Expenditure $-0.04B $-1.39B $-1.4B $-1.39B $-0.13B $-0.38B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 106.28
ACRS Aclaris Therapeutics, Inc. 1.34
ADVB Advanced Biomed Inc. Common Stock 1.81
APDN Applied DNA Sciences, Inc. 0.8471
AWH Aspira Women's Health Inc. 0.082
BDSX Biodesix, Inc. 0.539
BIAF bioAffinity Technologies, Inc. 0.499
BIAFW bioAffinity Technologies, Inc. 0.1711
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 4.3
BNR Burning Rock Biotech Limited 2.84
CDNA CareDx, Inc 18.48
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 0.79
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 114.66
CSTL Castle Biosciences, Inc. 20.63
DGX Quest Diagnostics Incorporated 173.76
DHR Danaher Corporation 197.14
ETFs With Exposure to AKU
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 270.64
IWC iShares Micro-Cap ETF 0.00006 110.33
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000311065 92.89
Unlock